Static Chart Seikagaku Corporation

Equities

Delayed Japan Exchange Other stock markets 10:08:43 2024-05-19 pm EDT			5-day change	1st Jan Change
780 ^JPY	-0.51%		+5.83%	+2.50%

Apr. 08	Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	CI
2023	Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Duration

Period